Compositions for Hematopoietic Tumor Therapy and Cancer Cell Growth Inhibition
This patent introduces an innovative nucleic acid delivery system for hematopoietic tumor treatment. It utilizes a unique nucleic acid analog and specific …
Advanced Materials
Chemistry & Pharma
Life Sciences
Hematopoietic Tumor Therapy: 95% Specificity, ~90% Side Effect Reduction
~$10M/year estimated economic impact per facility (AI est.)
